Skip to main content
Clinical Trials/CTRI/2024/04/066274
CTRI/2024/04/066274
Not yet recruiting
Phase 1

An Open-Label, Single Arm Clinical Study to Evaluate the Safety of HGLG-032406 (IN-100001206) in Healthy Adult Females. - Nil

Himalaya Wellness Company0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Himalaya Wellness Company
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Healthy adult females within age group of 18 to 40 years.
  • 2\.Healthy females as determined by the investigator based on a medical evaluation including medical history, physical examinations, and laboratory examinations.
  • 3\.Subjects willing to sign an informed consent document.
  • 4\.Subjects willing to adhere to protocol requirements throughout the study period.
  • 5\.Subjects who have not participated in any clinical study in the past 30 days

Exclusion Criteria

  • 1\.Subjects with known clinically significant serious cardiovascular, neurological, respiratory, gastrointestinal, genitourinary, congenital or any other disorder as determined by the investigator.
  • 2\.Women who are pregnant, nursing, or planning a pregnancy during study entry and throughout the duration of the study.
  • 3\.Subjects with lactose intolerance (as the IP is to be taken with milk).
  • 4\.Subjects with known allergies to any of the ingredients of the investigational product.
  • 5\.Subjects with clinically significant pre\-existing systemic disease necessitating long\-term medications as determined by the investigator.
  • 6\.Subjects not willing to refrain from using adequate contraception and hormonal medications one month prior and during the study.
  • 7\.Subjects not willing to refrain from taking any other similar supplements during the study period.
  • 8\.Subjects not willing to abstain from excessive intake of recreational products like tobacco/pan chewing, smoking, alcohol and any other as determined by the investigator during the study period.

Outcomes

Primary Outcomes

Not specified

Similar Trials